1.56 USD
▼+0.03-0.95%
盘后 1.57 -0.32%
2026-08-03
市值
$16.83M
市盈率
—
EPS
-2.83
股息率
—
52 周区间
1.45 – 5.68
成交量
35.68K
Beta
0.68
目标价
—
52W 低 1.4552W 高 5.68
价格走势
公司简介
Pluri Inc., a biotechnology company, engages in the research, development, and manufacture of cell-based products, cell therapeutics, and related technologies for various industries. The company develops placenta-based cell therapy product candidates for the treatment of inflammatory, muscle injuries, and hematologic conditions; and immunotherapy platform. Its product candidates include PLX-PAD, that is composed of maternal mesenchymal stromal cells originating from the placenta for the treatment of various indications, such as acute muscle inj...